Dynamic Neutrophil-to-Lymphocyte Ratio Stratifies Survival and Immune-Related Adverse Events in Lung and Gastric Cancer Patients with Immunotherapy

Chengcheng Qian, Mengting Wang, Chuyi Liu, Feng Liu, Wenying Zhang, Xiaohua Hu, Yanjie Zhang, Bin Jiang, Jiongyi Wang, Ming Xu, Haihua Yuan · 2026

Read Dynamic Neutrophil-to-Lymphocyte Ratio Stratifies Survival and Immune-Related Adverse Events in Lung and Gastric Cancer Patients with Immunotherapy by Chengcheng Qian, Mengting Wang, Chuyi Liu, Feng Liu, Wenying Zhang, Xiaohua Hu, Yanjie Zhang, Bin Jiang, Jiongyi Wang, Ming Xu, Haihua Yuan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13573851.txt.

Description

Chengcheng Qian and co-authors track a blood ratio in cancer patients on immune therapy in a 2026 study. The ratio, called NLR, sets neutrophils against lymphocytes, two white cell types. It has grown as a sign of how patients fare on checkpoint drugs, which free the immune system to attack tumors. The team asked how shifts in the ratio over time link to survival and side effects.

The study covered 101 patients with lung or stomach cancer. The ratio was read before care and at one and three months in. A high ratio at one month tracked with early immune side effects in both cancers. In lung cancer, a lower ratio at three months tracked with longer life and slower disease growth. The link was weaker for stomach cancer.

Catalog record

CREATORChengcheng Qian, Mengting Wang, Chuyi Liu, Feng Liu, Wenying Zhang, Xiaohua Hu, Yanjie Zhang, Bin Jiang, Jiongyi Wang, Ming Xu, Haihua Yuan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13573851

Browse the full library · About the Tower of Babel